In the US, the organ sales market has been experiencing a consistent downward trend over the past decade. From a peak value of 55.28 million USD in 2013, the market steadily declined to 36.1 million USD in 2023. This represents a significant reduction in market size.
Year-on-year variations have typically shown negative growth, with the largest recent drops seen in 2020 and 2023, at -10.15% and -6.07% respectively. The average compound annual growth rate (CAGR) over the last five years settled at approximately -5.64%, reflecting a consistent decrease in market size.
Future forecasts from 2024 through 2028 predict a continued decline, with the market expected to reach 23.91 million USD by 2028. This indicates an average annual shrinkage of -6.54%, translating to a cumulative expected drop of 28.7% over the five-year forecast period.
Future trends to watch for include potential shifts in market dynamics such as advancements in organ preservation technology, changes in healthcare policies, and the impact of emerging medical innovations like artificial organs or bioprinting, which may influence future market directions.
